256 related articles for article (PubMed ID: 25726258)
21. Rapid and sensitive screening and confirmation of thirty-four aminocarbonyl/carboxamide (NACA) and arylindole synthetic cannabinoid drugs in human whole blood.
Tynon M; Homan J; Kacinko S; Ervin A; McMullin M; Logan BK
Drug Test Anal; 2017 Jun; 9(6):924-934. PubMed ID: 27653946
[TBL] [Abstract][Full Text] [Related]
22. Identification of synthetic cannabinoids that were seized, consumed, or associated with deaths in Kuwait in 2018 using GC-MS and LC-MS-MS analysis.
Al-Matrouk A; Alqallaf M; AlShemmeri A; BoJbarah H
Forensic Sci Int; 2019 Oct; 303():109960. PubMed ID: 31550599
[TBL] [Abstract][Full Text] [Related]
23. Overview of Synthetic Cannabinoids ADB-FUBINACA and AMB-FUBINACA: Clinical, Analytical, and Forensic Implications.
Lobato-Freitas C; Brito-da-Costa AM; Dinis-Oliveira RJ; Carmo H; Carvalho F; Silva JP; Dias-da-Silva D
Pharmaceuticals (Basel); 2021 Feb; 14(3):. PubMed ID: 33669071
[TBL] [Abstract][Full Text] [Related]
24. Synthetic Cannabinoid and Mitragynine Exposure of Law Enforcement Agents During the Raid of an Illegal Laboratory - Nevada, 2014.
Tapp L; Ramsey JG; Wen A; Gerona R
MMWR Morb Mortal Wkly Rep; 2017 Dec; 66(47):1291-1294. PubMed ID: 29190268
[TBL] [Abstract][Full Text] [Related]
25. Schedules of controlled substances: temporary placement of four synthetic cannabinoids into Schedule I. Final order.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2014 Feb; 79(27):7577-82. PubMed ID: 24605391
[TBL] [Abstract][Full Text] [Related]
26. The 2-alkyl-2
Longworth M; Banister SD; Mack JBC; Glass M; Connor M; Kassiou M
Forensic Toxicol; 2016; 34():286-303. PubMed ID: 27547266
[TBL] [Abstract][Full Text] [Related]
27. Defining Steric Requirements at CB
Markham J; Sparkes E; Boyd R; Chen S; Manning JJ; Finlay D; Lai F; McGregor E; Maloney CJ; Gerona RR; Connor M; McGregor IS; Hibbs DE; Glass M; Kevin RC; Banister SD
ACS Chem Neurosci; 2022 Apr; 13(8):1281-1295. PubMed ID: 35404067
[TBL] [Abstract][Full Text] [Related]
28. Death Associated With the Use of the Synthetic Cannabinoid ADB-FUBINACA.
Shanks KG; Clark W; Behonick G
J Anal Toxicol; 2016 Apr; 40(3):236-9. PubMed ID: 26755539
[TBL] [Abstract][Full Text] [Related]
29. Occupational transdermal poisoning with synthetic cannabinoid cumyl-PINACA.
Dobaja M; Grenc D; Kozelj G; Brvar M
Clin Toxicol (Phila); 2017 Mar; 55(3):193-195. PubMed ID: 28084855
[TBL] [Abstract][Full Text] [Related]
30. Four types of cannabimimetic indazole and indole derivatives, ADB-BINACA, AB-FUBICA, ADB-FUBICA, and AB-BICA, identified as new psychoactive substances.
Qian Z; Hua Z; Liu C; Jia W
Forensic Toxicol; 2016; 34():133-143. PubMed ID: 26793280
[TBL] [Abstract][Full Text] [Related]
31. Impaired Driving Associated with the Synthetic Cannabinoid 5f-Adb.
McCain KR; Jones JO; Chilbert KT; Patton AL; James LP; Moran JH
J Forensic Sci Criminol; 2018 Aug; 6(1):. PubMed ID: 30956998
[TBL] [Abstract][Full Text] [Related]
32. Identification of a novel bromoindazole synthetic cannabinoid analogue in seized e-cigarette liquid: ADB-BRINACA.
Choi H; Kim S; Jang H; Kim HJ; Choe S
Forensic Sci Int; 2022 Sep; 338():111385. PubMed ID: 35863161
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of Synthetic Cannabinoid Metabolites in Human Blood in the Absence of Parent Compounds: A Stability Assessment.
Krotulski AJ; Bishop-Freeman SC; Mohr ALA; Logan BK
J Anal Toxicol; 2021 Feb; 45(1):60-68. PubMed ID: 32435808
[TBL] [Abstract][Full Text] [Related]
34. Enantioseparation of the carboxamide-type synthetic cannabinoids N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide and methyl [1-(5-fluoropentyl)-1H-indazole-3-carbonyl]-valinate in illicit herbal products.
Doi T; Asada A; Takeda A; Tagami T; Katagi M; Kamata H; Sawabe Y
J Chromatogr A; 2016 Nov; 1473():83-89. PubMed ID: 27773389
[TBL] [Abstract][Full Text] [Related]
35. 5F-Cumyl-PINACA in 'e-liquids' for electronic cigarettes: comprehensive characterization of a new type of synthetic cannabinoid in a trendy product including investigations on the in vitro and in vivo phase I metabolism of 5F-Cumyl-PINACA and its non-fluorinated analog Cumyl-PINACA.
Angerer V; Franz F; Moosmann B; Bisel P; Auwärter V
Forensic Toxicol; 2019; 37(1):186-196. PubMed ID: 30636986
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and
Cannaert A; Sparkes E; Pike E; Luo JL; Fang A; Kevin RC; Ellison R; Gerona R; Banister SD; Stove CP
ACS Chem Neurosci; 2020 Dec; 11(24):4434-4446. PubMed ID: 33253529
[TBL] [Abstract][Full Text] [Related]
37.
Carlier J; Diao X; Wohlfarth A; Scheidweiler K; Huestis MA
Curr Neuropharmacol; 2017 Jul; 15(5):682-691. PubMed ID: 29403341
[TBL] [Abstract][Full Text] [Related]
38. UPLC-HR-MS/MS-based determination study on the metabolism of four synthetic cannabinoids, ADB-FUBICA, AB-FUBICA, AB-BICA and ADB-BICA, by human liver microsomes.
Li J; Liu C; Li T; Hua Z
Biomed Chromatogr; 2018 Mar; 32(3):. PubMed ID: 28992356
[TBL] [Abstract][Full Text] [Related]
39. Cannabinoid-like effects of five novel carboxamide synthetic cannabinoids.
Gatch MB; Forster MJ
Neurotoxicology; 2019 Jan; 70():72-79. PubMed ID: 30439379
[TBL] [Abstract][Full Text] [Related]
40. Detection and quantification of 5F-ADB and its methyl ester hydrolysis metabolite in fatal intoxication cases by liquid chromatography-high resolution mass spectrometry.
Yeter O; Erol Öztürk Y
Forensic Sci Int; 2019 Sep; 302():109866. PubMed ID: 31302415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
